Marwa R. El-Zahry

Marwa R. El-Zahry


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Talanta
Verified
Journal Article
Closed access
MEMarwa R. El-Zahry
Marwa R. El-Zahry
IRIbrahim H. Refaat
Ibrahim H. Refaat
HMHorria A. Mohamed
Horria A. Mohamed
ERErwin Rosenberg
Erwin Rosenberg
BLBernhard Lendl
Bernhard Lendl

1 March 2018 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
MEMarwa R. El-Zahry
Marwa R. El-Zahry
BLBernhard Lendl
Bernhard Lendl

1 March 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
MEMarwa R. El-Zahry
Marwa R. El-Zahry
MAMarwa F. B. Ali
Marwa F. B. Ali
The enhancement effect of reduced graphene oxide (rGO) combined with silver nanocomposite supported on poly brilliant blue (PBB) platform was investigated for ultra-trace analysis of rosuvastatin (RS). Herein, in situ electrochemical deposition of the silver nanoparticles (AgNPs) and rGO hybrid was performed on the surface of the polymerized brilliant blue (PBB) platform. The developed (AgNPs–rGO/PBB) electrode showed an enhanced catalytic activity toward the oxidation of RS. The modified electrodes AgNPs–rGO/PBB and AgNPs/PBB required an overpotential of 0.68 and 1.06 V to achieve a current density of 10 mA cm−2, and their corresponding Tafel slopes were calculated to be 70 and 105 mV dec−1, respectively. Further, rGO and silver nanocomposites properties were characterized by scanning electron microscopy (SEM), cyclic voltammetry (CV), square wave voltammetry (SWV), linear sweep voltammetry (LSV), and electrochemical impedance spectroscopy (EIS). Additionally, the formation of GO and AgNPs–rGO was confirmed by Raman spectroscopy and Fourier transform infrared spectroscopy (FT-IR). Under the optimized conditions, the electrochemical sensor showed a remarkable response for quantitation of RS over a wide range of concentrations 5 × 10−9 to 5 × 10−7 mol L−1 (r = 0.9988), with a limit of detection 2.17 × 10−9 mol L−1. The electrochemical performance of the studied electrode showed high reproducibility and suitability for tablets and human plasma.

4 October 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
MAMarwa F. B. Ali
Marwa F. B. Ali
MEMarwa R. El-Zahry
Marwa R. El-Zahry
Different electrodeposited NiCo2O4 microspheres supported on a reduced graphene oxide platform for electrochemical sensing of venlafaxine.

23 April 2016 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MEMarwa R. El-Zahry
Marwa R. El-Zahry
IRIbrahim H. Refaat
Ibrahim H. Refaat
HMHorria A. Mohamed
Horria A. Mohamed
BLBernhard Lendl
Bernhard Lendl

17 January 2018 in Journal of Analytical Methods in Chemistry
Verified
Journal Article
Open access
PDF file
MEMarwa R. El-Zahry
Marwa R. El-Zahry
This contribution describes a simple, fast, and sensitive application of localized surface plasmon resonance effect of silver nanoparticles for simultaneous determination of antihypertensive drugs’ mixture atenolol and amiloride in both pharmaceutical dosage forms and in biological samples (urine). Silver nanoparticles were prepared by chemical reduction of silver nitrate using hydroxylamine HCL in an alkaline medium. Application of silver-hydroxylamine nanoparticles (SH NPs) provides many advantages including reproducibility, sensitivity, and cost effective way of analyte determination. Amiloride has four amino groups which act as attachment points on the surface of silver nanoparticles resulting in a synergistic effect on the absorption intensity of atenolol, leading to increase the sensitivity of the determination of both compounds. This method shows excellent advantages comparing with the previously reported methods, including accuracy, precision, and selectivity. The linear range of atenolol is 1 × 10−5–1 × 10−4 mol·L−1 and of amiloride is 1 × 10−6–1 × 10−5 mol·L−1. The limit of detection (LOD) values of atenolol and amiloride are 0.89 × 10−5 and 0.42 × 10−6 mol·L−1, respectively.